Leveraging diagnostics for precision health
The impact of precision health is rapidly accelerating, powered by advances in biosciences (gene sequencing, microbiome and epigenetics) and digital technologies (data analytics, artificial intelligence, biosensors and digital health strategies).
Australia has an opportunity to build a healthier and wealthier Australia by harnessing its world‑class expertise, in medical research, digital health, agrifood and medical technologies, to help lead global advances in precision health.
Explore our diagnostics research
Advanced medical diagnostics
The evolving diagnostics industry in Australia is facilitating a shift from managing chronic diseases as they arise to detecting them well before they've had a chance to take hold. We're developing solutions to detect and prevent chronic diseases like cancer, Alzheimer’s disease and metabolic diseases from occurring.
Our research in protein and DNA biomarkers for colorectal cancer disease detection and prevention
Blood Tube Coatings
We partnered with Q-Sera to manufacture a formulation of RAPClot, a coagulant used in blood tests. We developed an entire workflow allowing for easy production of RAPClot coated blood test tubes.
Brain imaging software
We're helping improve the diagnosis of brain disorders through user-friendly software that can monitor EEG signals and generate a 3D localisation of abnormal electrical activity.
Tests for bowel cancer
A new, more sensitive blood test for post-surgical bowel cancer recurrence, developed by CSIRO scientists, has been launched in the US.
We're building a healthier and wealthier Australia by precisely anticipating and preventing disease
Monitoring chronic disease
Delivering healthcare via telecommunications could open up home monitoring of aged care patients with chronic diseases, improving health outcomes and significantly saving costs.
Make a good night’s sleep your 2019 New Year’s resolution
Australia’s national science agency, CSIRO, has helped bring to market a new treatment to cure the potentially fatal obstructive sleep apnoea.
New $5m research project to treat ‘untreatable’ cancers
Cancer patients in Australia may soon have earlier access to revolutionary, highly targeted new treatment options through a $5.1M research partnership, announced today by the national science agency CSIRO and GenesisCare, one of Australia’s largest cancer care providers.
Solving the mystery of Ned Kelly's remains
For the first time since his death 136 years ago a comprehensive study of scientific evidence has revealed the secrets of Ned Kelly, uncovering the truth of his burial, post-mortem and what became of his skull.
'ILRUN': CSIRO’s immunity gene named
A potentially game changing gene identified by Australia’s national science agency, CSIRO, has been granted the name 'ILRUN' by the Human Genome Nomenclature Committee (HGNC).
DNA study to reveal age old secrets of whale sharks
This World Oceans Day, CSIRO scientists will be conducting a world first by collecting DNA samples from the whale shark population at Ningaloo Reef, Western Australia, to determine their age, while also unlocking the secrets of where they travel to and how deep they go.
Home monitoring of chronic disease could save up to $3 billion a year
Australia’s first large-scale trial of telehealth has shown that it could save up to $3 billion a year to the nation’s healthcare system.
‘Sunrise Industries’ to transform the ASEAN region
A study from CSIRO’s Data61 has identified the top seven emerging industries within ASEAN and neighbouring nations that will fuel future regional growth, international collaboration and job creation.
Coviu raises $1m to bring more interactive digital consultations to the healthcare sector
Coviu, a spinout of CSIRO’s Data61, has raised $1m from venture capital firm Main Sequence Ventures to provide Australians with greater access to interactive medical treatment in the comfort of their own homes.
Heart attack app becomes science spin-out
A solution to help dramatically improve recovery from a heart attack has become a venture backed spin-out from the national science and technology accelerator program, known as ON.
AI technology to help prevent blindness
It could soon be easier to prevent blindness in the 1.7 million Australians living with diabetes thanks to the successful trial of a world first artificial intelligence-driven technology in Perth.
Making full knee recovery remotely possible
In collaboration with leading medical device manufacturer Johnson & Johnson Medical Devices, CSIRO has launched the trial of a ground-breaking digital platform to help patients recover from total knee replacements.
Diagnostic emergency response laboratory
The Diagnostic Emergency Response Laboratory is a high throughput diagnostic laboratory, designed to handle up to 10 000 samples a day in outbreak mode.
Pain intervention app
We’ve teamed up with Metro North Hospital and Health Service and the University of Queensland to develop a mobile platform for pain intervention.
Knee replacement rehab app
We've developed a digital support platform to help patients prepare for and recover from total knee replacements.
A point-of-care technology suitable for a range of industries including defence, health, food and beverage, biosecurity and civilian security.
Chatbot app for therapy
We’ve developed a unique smartphone chatbot app that uses artificial intelligence to provide at-home social and communication therapy.
Faster drug discovery
We have developed software that rapidly and accurately provides vital information on cells to aid drug discovery and biological research.
We're developing smarter ways to monitor our health and wellbeing for earlier detection and better treatment of injury and disease.
Detecting Alzheimer's disease
We’re working to develop a non-invasive saliva test for the early detection of Alzheimer’s disease.